Quest Diagnostics, Inc. (DGX) Tops Q4 EPS by 4c; Guides

January 30, 2014 7:47 AM

Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $0.97, $0.04 better than the analyst estimate of $0.93. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found